Pratik Joshi
University Health Network(CA)University of Toronto(CA)Princess Margaret Cancer Centre(CA)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, RNA modifications and cancer, Acute Lymphoblastic Leukemia research, Acute Myeloid Leukemia Research, RNA Interference and Gene Delivery
Most-Cited Works
- → In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target(2023)15 cited
- → The State and Fate of Linguistic Diversity and Inclusion in the NLP\n World(2020)7 cited
- → RNA binding protein‐directed control of leukemic stem cell evolution and function(2024)4 cited
- → 3171 – IDENTIFYING STRESS GRANULES AS DETERMINANTS OF LEUKEMIA STEM CELL MAINTENANCE AND STRESS ADAPTATION(2024)1 cited
- → Aberrant Splicing of MBD1 Reshapes the Epigenome to Drive Convergent Myeloerythroid Defects in MDS(2023)1 cited
- → Data from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target(2023)
- → Supplementary Figure S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target(2023)
- → Supplementary Figure S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target(2023)
- → Isolation, Identification, Chemical and Biological Synthesis of silver nanoparticles andits Antimicrobial Activity(2023)
- → Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target(2025)